Scholar Rock Holding Corporation
NASDAQ:SRRK · NASDAQ Global Select
+$0.49 today
Vol 2.37M · Avg 1.46M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+42.22%
Period High
$51.51
Period Low
$27.92
Latest
$47.33
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Cidara Therapeutics, Inc.
CDTX
$5.61B
Legend Biotech Corporation
NASDAQ:LEGN
$5.35B
Xenon Pharmaceuticals Inc.
NASDAQ:XENE
$4.26B
Kiniksa Pharmaceuticals, Ltd.
NASDAQ:KNSA
$4.14B
Beam Therapeutics Inc.
NASDAQ:BEAM
$3.45B
IDEAYA Biosciences, Inc.
NASDAQ:IDYA
$3.01B
Adaptive Biotechnologies Corporation
NASDAQ:ADPT
$2.77B
Disc Medicine, Inc.
NASDAQ:IRON
$2.72B
Zai Lab Limited
NASDAQ:ZLAB
$2.12B
Mineralys Therapeutics, Inc.
NASDAQ:MLYS
$1.69B
What is the latest SRRK filing?
The latest filing shown is 4 dated Jun 8, 2026.
How many recent filings does SRRK have?
Intrinsic Alpha currently shows 20 recent filings for SRRK.
Explore More
Continue the stock analysis
Jump to another research area for this company.